Gut check: your microbiome may predict arthritis drug success

NCT ID NCT04899154

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether the types of bacteria in your gut can predict how well you will respond to biologic drugs for spondyloarthritis, a group of inflammatory conditions affecting the spine and joints. Researchers will compare the gut bacteria of 80 people starting biotherapy and see if certain bacteria patterns are linked to better treatment outcomes. The goal is to help doctors choose the right treatment from the start, avoiding trial-and-error.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPONDYLOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Spondylarthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Européen Marseille

    RECRUITING

    Marseille, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••